ARCHIVES

Seattle Times, The Hutch Duel Over Five-Part Series.

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | March 23, 2001

Download PDF Visit The Full Archive

Related Articles

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

Niccotine Reports As Aiding Metastasis

August 22, 1986

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012

Genomic Health Presents Meta-Analyses of Oncotype DX

January 28, 2011

Judge Clears Way For Trial Pitting FDA Against Physicians Over First Amendment

March 24, 1995